Results 191 to 200 of about 214,979 (267)
Potential Benefits of Gut Microbiota Modulation in Chronic Obstructive Pulmonary Disease. [PDF]
Li J, Zhang H, Zhang P, Hu J.
europepmc +1 more source
ABSTRACT Amenamevir is a novel anti‐herpes zoster drug that is increasingly used in Japan because of its once‐daily administration and lack of renal dose adjustment requirements. However, evidence of its clinical effectiveness is limited. This study aimed to estimate the clinical effectiveness of amenamevir vs. valacyclovir in preventing zoster‐related
Yasuhiro Kano +2 more
wiley +1 more source
ABSTRACT Introduction Accurate preoperative physiological assessment is critical for high‐risk patients undergoing lung resection to predict postoperative lung function. This study compared quantitative dual‐energy CT (DECT) perfusion with SPECT/CT for lobar perfusion mapping in an at‐risk oncological cohort.
Jack Edward Liu +6 more
wiley +1 more source
Prevalence, pathogenesis, and clinical impact of pulmonary hypertension associated with chronic obstructive pulmonary disease. [PDF]
Scabello RT +6 more
europepmc +1 more source
Does adding digital inhalers to asthma triple therapy result in quadruple therapy?
Job F.M. van Boven, Amber A. Eikholt
doaj +1 more source
Abstract Background and aim In a randomised open‐label trial among hospitalised patients with atherosclerotic vascular disease, motivational smoking cessation counselling with proactive referral to community‐based follow‐up was more effective than brief cessation advice and written information, with 6‐month continuous abstinence rates of 49.5% vs. 24.5%
Karin Pleym +9 more
wiley +1 more source
Small Airway Disease in Pre-COPD and Early COPD: Insights Into the Pulmonary "Silent Zone". [PDF]
Li J, Liu L, Tang J, He C, Pu G, Sun J.
europepmc +1 more source
Abstract Background and aims Opioid use disorder (OUD) treatment guidelines worldwide recommend opioid agonist treatment (OAT) as a long‐term, potentially indefinite treatment for managing OUD. However, many individuals express a strong interest in eventually tapering fully off treatment.
Ruyu Yan +13 more
wiley +1 more source
Identifying and validating ITGB2 and HNRNPAB as diagnostic biomarkers in chronic obstructive pulmonary disease using bioinformatics and Integrated Machine Learning Methods. [PDF]
Zhang F +8 more
europepmc +1 more source

